Type 2 Diabetes Archive

Does Professional CGM Decrease the Economic Burden of T2D?

Does Professional CGM Decrease the Economic Burden of T2D?

Professional continuous glucose monitoring can significantly reduce the economic burden of type 2 diabetes.

Rate of Undiagnosed Diabetes in the United States

Rate of Undiagnosed Diabetes in the United States

Undiagnosed diabetes is a relatively small fraction of the total diabetes population when a confirmatory definition is used.

Patient Nonadherence Often Misidentified as Diabetes Treatment Failure

Patient Nonadherence Often Misidentified as Diabetes Treatment Failure

Second-line treatments are often initiated without first using first-line therapies.

Type 2 Diabetes Protective Against Aortic Aneurysm, Dissection

Type 2 Diabetes Protective Against Aortic Aneurysm, Dissection

Studies have not previously examined long-term risks or mortality after aortic aneurysm or dissection in people with type 2 diabetes.

T2D and Magnesium Intake: Risk of Incident Diabetes Examined

T2D and Magnesium Intake: Risk of Incident Diabetes Examined

Higher magnesium intake was linked to a 15% lower risk for type 2 diabetes.

Cognitive Status in T2D: Retinal Sensitivity Predictive of Neurodegeneration

Cognitive Status in T2D: Retinal Sensitivity Predictive of Neurodegeneration

Retinal sensitivity, assessed by microperimetry, is related to brain neurodegeneration in T2D.

Diabetes Following Pancreatic Disease Often Misclassified as T2D

Diabetes Following Pancreatic Disease Often Misclassified as T2D

Diabetes following pancreatic disease often requires higher use of insulin and worse glycemic control.

Ventricular Function With Vildagliptin in T2D and CHF

Ventricular Function With Vildagliptin in T2D and CHF

Study highlights the need to examine the safety of new glucose-lowering treatments specifically in patients with diabetes and heart failure and reduced ejection fraction.

DPP4-i Plus α-Glucosidase Inhibitor Reduces HbA1c in T2D

DPP4-i Plus α-Glucosidase Inhibitor Reduces HbA1c in T2D

People with T2D experienced greater HbA1c reductions with the addition of a DPP4 inhibitor vs placebo.

SSRIs and SNRIs Linked to Type 2 Diabetes in Children, Adolescents

SSRIs and SNRIs Linked to Type 2 Diabetes in Children, Adolescents

A recent population-based study is the first to examine the risk of type 2 diabetes associated with the use of antidepressant medication in children and adolescents.

HbA1c Predictive of Poor Heart Failure Outcomes in T2D

HbA1c Predictive of Poor Heart Failure Outcomes in T2D

Based on glycemic control and treatment method, type 2 diabetes in the heart failure population can be indicative of various risk associations.

Sudden Death in T2D: Examining the Most Common Cause of CV Mortality

Sudden Death in T2D: Examining the Most Common Cause of CV Mortality

Heart failure prevention may be an opportunity to reduce the risk of death in specific cardiovascular subcategories.

FDA Approves Exenatide Extended-Release Injection for T2D

FDA Approves Exenatide Extended-Release Injection for T2D

The new formulation of Bydureon BCise allows for once-weekly administration with an autoinjector pen.

Improved Outcomes in Prediabetes, T2D With Liraglutide

Improved Outcomes in Prediabetes, T2D With Liraglutide

The efficacy of liraglutide therapy was examined in metformin-treated subjects with obesity.

High-Dose Beta-Blockers More Effective in Chronic Heart Failure, Diabetes

High-Dose Beta-Blockers More Effective in Chronic Heart Failure, Diabetes

Greater prognostic advantages were associated with high-dose beta blockers in chronic heart failure with diabetes.

Reducing HbA1c in T1D and T2D With Flash Glucose Monitoring

Reducing HbA1c in T1D and T2D With Flash Glucose Monitoring

Overall reduction in HbA1c was higher in people with T2D vs those with T1D.

T2D Therapies: Tofogliflozin Efficacy With High Baseline Insulin

T2D Therapies: Tofogliflozin Efficacy With High Baseline Insulin

HbA1c, fasting plasma glucose, and body weight were significantly reduced in all patients taking tofogliflozin.

Trick or Treat: Tips for Diabetes Management on Halloween

Trick or Treat: Tips for Diabetes Management on Halloween

With a little communication, children with diabetes can still enjoy Halloween festivities.

Examining Melancholia and Atypical Depression in T1D and T2D

Examining Melancholia and Atypical Depression in T1D and T2D

Twenty-five percent of people with type 2 diabetes and 12% of people with type 1 diabetes had depression.

VA, DoD Release New T2D Clinical Practice Guideline

VA, DoD Release New T2D Clinical Practice Guideline

The update provides guidance within 7 areas of type 2 diabetes management, including patient centered care and individualized treatment plans.

Insulin Plus Sulfonylurea, Metformin Linked to HbA1c Reduction

Insulin Plus Sulfonylurea, Metformin Linked to HbA1c Reduction

However, sulfonylurea plus insulin was linked to more hypglycemic events than insulin alone.

Preventing T2D With Referral to Commercial Weight Management Program

Preventing T2D With Referral to Commercial Weight Management Program

Referral to a commercial weight management program, such as Weight Watchers, can be effective in preventing diabetes.

T2D Remission, Weigh Loss Associated With Roux-en-Y Surgery

T2D Remission, Weigh Loss Associated With Roux-en-Y Surgery

Researchers have identified lasting benefits for patients with severe obesity who undergo Roux-en-Y gastric bypass surgery.

Medicare Recipients Overtreated for Diabetes

Medicare Recipients Overtreated for Diabetes

For medicare recipients it is more common to be overtreated than undertreated for diabetes.

AMA: Encouraging Patients to Explore Diabetes Risk Through Tablet Use

AMA: Encouraging Patients to Explore Diabetes Risk Through Tablet Use

One clinic shares results after replacing magazines with tablets allowing patients to examine their risk of developing diabetes.

Diabetes and Renal Outcomes: Reduced Progression of Kidney Disease With Liraglutide Tx

Diabetes and Renal Outcomes: Reduced Progression of Kidney Disease With Liraglutide Tx

Liraglutide plus usual care resulted in lower rates of diabetic kidney disease-specific outcomes in type 2 diabetes.

Predicting Rapid Reduction in Renal Function Using Plasma Biomarkers

Predicting Rapid Reduction in Renal Function Using Plasma Biomarkers

Researchers identified several novel plasma biomarkers that can be used to predict rapid decline in renal function in T2D, independent of traditional risk factors.

Diabetes Self-Management Class Participation Varies in Adults with T2D

Diabetes Self-Management Class Participation Varies in Adults with T2D

Clinicians should identify barriers to patient participation in diabetes self-management classes.

Examining Inclusion of T2D Medication Adherence Data in Studies

Examining Inclusion of T2D Medication Adherence Data in Studies

Results suggest that medication adherence is associated with reduced risk of all-cause mortality in T2D.

Predicting Adult MetS, T2D, CV Risks in Childhood

Predicting Adult MetS, T2D, CV Risks in Childhood

BMI measurement alone can also be used to determine associations between childhood and adulthood conditions.

Reducing ED Visits, Hospital use With T2D Risk Assessment Tool

Reducing ED Visits, Hospital use With T2D Risk Assessment Tool

Validation-tool identified "high risk" patients were more likely to report hypoglycemia episodes and subsequent emergence department use.

HbA1c vs Fasting Plasma Glucose for Prediabetes, Diabetes Diagnosis

HbA1c vs Fasting Plasma Glucose for Prediabetes, Diabetes Diagnosis

The efficacy of diagnosing diabetes or prediabetes using fasting plasma glucose vs traditional HbA1c test was examined.

Second-Generation Antipsychotics: Is Diabetes Risk Increased in Children and Adolescents?

Second-Generation Antipsychotics: Is Diabetes Risk Increased in Children and Adolescents?

The study included over 45,000 children using second-generation antipsychotic medications between 2009 and 2013.

Glucagon Response to Hypoglycemia Altered in Diabetes Secondary to Chronic Pancreatitis

Glucagon Response to Hypoglycemia Altered in Diabetes Secondary to Chronic Pancreatitis

Patients with type 2 diabetes and those with diabetes secondary to chronic pancreatitis have similarly impaired α-cell responses to oral glucose ingestion and hypoglycemia.

No Fingerstick Necessary: FDA Approves Novel Continuous Glucose Monitoring System for Diabetes

No Fingerstick Necessary: FDA Approves Novel Continuous Glucose Monitoring System for Diabetes

New monitoring system involves the placement of a small sensor wire beneath the skin surface to continuously monitor glucose levels.

Predicting Coronary Artery Events in T2D With Imaging Plus Risk Factor Assessment

Predicting Coronary Artery Events in T2D With Imaging Plus Risk Factor Assessment

Patients with MACE showed a greater extent of more severe coronary artery disease.

Fatty Acid Remodeling Common in T2D Following Bariatric Surgery

Fatty Acid Remodeling Common in T2D Following Bariatric Surgery

Researchers examined how adipocyte size reduction and fatty acid metabolism contribute to remission in type 2 diabetes following bariatric surgery.

Reducing HbA1c in T2D: Efficacy of Immune-Modulator Anti-Inflammatory Treatments

Reducing HbA1c in T2D: Efficacy of Immune-Modulator Anti-Inflammatory Treatments

Diacerein was well-tolerated among trial participants, and may be an acceptable adjunct treatment in type 2 diabetes.

Counseling vs Standard Care to Increase Physical Activity in T2D

Counseling vs Standard Care to Increase Physical Activity in T2D

Three hundred physically inactive or sedentary patients received either theoretical and practical counseling once-yearly for 3 years, or standard care.

Inverse Relationship Between Sleep Duration and Risk of T2D in Children

Inverse Relationship Between Sleep Duration and Risk of T2D in Children

Researchers identified strong inverse graded relationships between children's sleep duration, adiposity, and the presence of diabetes risk markers.

Can Sustained Weight Loss Lead to Remission of T2D?

Can Sustained Weight Loss Lead to Remission of T2D?

Weight loss in people with type 2 diabetes is associated with extended life expectancy.

Atrial Fibrillation With Diabetes: Risk for Cardiovascular Events in Women vs Men

Atrial Fibrillation With Diabetes: Risk for Cardiovascular Events in Women vs Men

Women with atrial fibrillation and diabetes had a higher risk for mortality and cardiovascular complications compared with men.

Type 2 Diabetes Weight Regain Not Prevented With Group CBT

Type 2 Diabetes Weight Regain Not Prevented With Group CBT

Researchers examined the efficacy of cognitive behavioral group therapy on preventing weight regain or modifying cardiovascular risk factors and psychological well-being.

Examining Cold-Related Cardiorespiratory Symptoms in T2D

Examining Cold-Related Cardiorespiratory Symptoms in T2D

Worsening glycemic status is linked to increased reports of individual cardiorespiratory symptoms, including dyspnea, cough, chest pain, and arrythmia.

Does PCOS Increase T2D Event Rate?

Does PCOS Increase T2D Event Rate?

Among women with polycystic ovary syndrome, type two diabetes was more common and diagnosed at a younger age than in control groups.

Increasing Glycemic Control With Continuous Glucose Monitoring in T2D

Increasing Glycemic Control With Continuous Glucose Monitoring in T2D

Study results support an additional management method for glycemic control in patients with T2D.

How Does Lifestyle Intervention Benefit Glycemic Control in T2D?

How Does Lifestyle Intervention Benefit Glycemic Control in T2D?

Researchers examined the efficacy of lifestyle intervention on glycemic control in type 2 diabetes.

Predicting Emergency Department or Hospital Visits in T2D Adverse Events

Predicting Emergency Department or Hospital Visits in T2D Adverse Events

Over 150 variables were identified as possible hypoglycemia risk factors.

Treatment Delays in T2D Increase Cardiovascular Biomarkers

Treatment Delays in T2D Increase Cardiovascular Biomarkers

Serum NT-proBNP and serum hsTnl levels were examined at baseline, 26, 52, and 104 weeks.

Ipragliflozin vs Pioglitazone for NAFLD in T2D

Ipragliflozin vs Pioglitazone for NAFLD in T2D

Ipragliflozin showed "equally beneficial effects" on glycemic control in patients with nonalcoholic fatty liver disease and type 2 diabetes.

GSK Announces Discontinuation of Injectable Therapy for T2D

GSK Announces Discontinuation of Injectable Therapy for T2D

GlaxoSmithKline expects Tanzeum supplies to be depleted by July 2018.

FDA: Liraglutide Approved for MACE in T2D With Established CVD

FDA: Liraglutide Approved for MACE in T2D With Established CVD

Approval for the new indication follows a review of the results of the LEADER trial.

Diabetes Risk Lowered With Regular Alcohol Consumption

Diabetes Risk Lowered With Regular Alcohol Consumption

The lowest risk of diabetes was observed at 14 drinks per week in men and at 9 drinks per week in women.

HbA1c, Fasting Plasma Glucose Predictive of Alzheimer's in T2D

HbA1c, Fasting Plasma Glucose Predictive of Alzheimer's in T2D

In a study of Taiwanese patients with type 2 diabetes, researchers examined the link between HbA1c and Alzheimer's disease.

Reducing Hypoglycemia in T1D and T2D: Insulin Degludec vs Insulin Glargine

Reducing Hypoglycemia in T1D and T2D: Insulin Degludec vs Insulin Glargine

Compared with insulin glargine, insulin degludec significantly reduced rates of hypoglycemia in patients with either type 1 or type 2 diabetes.

Efficacy of Online, Team-Based Game to Reduce HbA1C Explored

Efficacy of Online, Team-Based Game to Reduce HbA1C Explored

Sustained reduction in HbA1c has been linked to participation in an online diabetes self-management education game.

Diabetes Treatments

Antidiabetic agents for the treatment of diabetes including maintenance and max doses.

Blood Glucose Meter Comparisons

Blood glucose meters comparison chart including injection site, sample size, range, result time, calibration method, memory size, and battery type.

Insulin Therapy Initiation in T2D Associated With Sedentary Behavior, Weight Increases

Insulin Therapy Initiation in T2D Associated With Sedentary Behavior, Weight Increases

Patients with type 2 diabetes who were initiated on insulin therapy increased their sitting time and decreased their low-intensity physical activity.

Blood Glucose Meter Compatibility with Lancets and Test Strips

Blood Glucose Meter Compatibility with Lancets and Test Strips chart

Heart Failure in Type 2 Diabetes: Improving the Risk Model

Heart Failure in Type 2 Diabetes: Improving the Risk Model

N-terminal pro-B-type natriuretic peptide showed the strongest association with heart failure in patients with type 2 diabetes.

Managing Osteoporosis With Type 2 Diabetes: An Expert Opinion

Managing Osteoporosis With Type 2 Diabetes: An Expert Opinion

Researchers conducted a systematic review of available literature to create a guide for optimal management of patients with type 2 diabetes and osteoporosis.

High Risk of Insulin Resistance, PTSD Biomarkers in Military Veterans

High Risk of Insulin Resistance, PTSD Biomarkers in Military Veterans

Eighty-three veterans with PTSD participated in a study examining biological pathways between PTSD and metabolic diseases.

Reducing CV Risk in T2D With Electronic Messaging Intervention

Reducing CV Risk in T2D With Electronic Messaging Intervention

Between-group differences in HbA1c, total and LDL-cholesterol, and psoprandial plasma glucose and insulin were statistically significant.

Positive Outcomes in Oral Glucose Challenge With Resistance Training in T2D

Positive Outcomes in Oral Glucose Challenge With Resistance Training in T2D

Seventeen sedentary patients underwent 6 weeks of whole-body resistance training.

T2D Risk Prediction in Women With Premature or Early Onset Menopause

T2D Risk Prediction in Women With Premature or Early Onset Menopause

Data from the Rotterdam Study were used to assess the relationship between age at menopause onset and type 2 diabetes risk.

Management of Hypoglycemia: Insulin Degludec vs Insulin Glargine

Management of Hypoglycemia: Insulin Degludec vs Insulin Glargine

Expert Q&A compares the effects of insulin degludec and insulin glargine U100 in patients with type 1 and type 2 diabetes.

Obstructive Sleep Apnea And Type 2 Diabetes: Complications and Treatments

Obstructive Sleep Apnea And Type 2 Diabetes: Complications and Treatments

Obstructive sleep apnea is associated with sight-threatening diabetic retinopathy in patients with type 2 diabetes.

Lusduna Nexvue Follow-On Biologic Tentatively Approved by FDA

Lusduna Nexvue Follow-On Biologic Tentatively Approved by FDA

Tentative FDA approval has been granted to Merck's follow-on biologic basal insulin injection.

Two-Hour Postload Glucose Test as Predictor of Cardiovascular Events

Two-Hour Postload Glucose Test as Predictor of Cardiovascular Events

Two-hour postload glucose better predicted cardiovascular events compared with fasting plasma glucose and HbA1c.

Link Between Diabetes and Hospital Readmission Rates

Link Between Diabetes and Hospital Readmission Rates

Patients with diabetes had higher hospital readmission rates compared with patients who did not have diabetes.

Poll: Type 2 Diabetes Medications

Poll: Type 2 Diabetes Medications

Take a moment to participate in this poll on medications you prescribe to your patients with type 2 diabetes.

Relationship Between Psoriasis and Cardiometabolic Comorbidities Examined

Relationship Between Psoriasis and Cardiometabolic Comorbidities Examined

Comorbidities included hyperlipidemia, hypertension, and type 2 diabetes, among others.

Increased Dysglycemia Screening With EHR-Supported Intervention

Increased Dysglycemia Screening With EHR-Supported Intervention

Intervention-based dysglycemia screening improved outcomes in study participants at 5 urban clinics.

Major Adverse CV Event Prediction Via Coronary CT Angiography in T2D

Major Adverse CV Event Prediction Via Coronary CT Angiography in T2D

Extent and severity of coronary artery disease was examined in over 900 patients with type 2 diabetes.

SGLT2 Inhibitors May Reduce Blood Pressure in Type 2 Diabetes

SGLT2 Inhibitors May Reduce Blood Pressure in Type 2 Diabetes

Sodium-glucose cotransporter 2 inhibitors reduced both systolic and diastolic blood pressure in patients with type 2 diabetes.

Diabetes and Mental Illness: How Are They Linked?

Diabetes and Mental Illness: How Are They Linked?

The prevalence of diabetes and impairment in glucose metabolism are noticeably higher in psychiatric patients.

Efficacy of Antimicrobial Treatments In Diabetic Foot Ulcers Examined

Efficacy of Antimicrobial Treatments In Diabetic Foot Ulcers Examined

Researchers examined 22 randomized controlled trials to evaluate effects of various treatments on diabetic foot ulcers.

Examining Therapeutic Inertia in Type 2 Diabetes

Examining Therapeutic Inertia in Type 2 Diabetes

Researchers examined patterns and predictors of treatment intensification in type 2 diabetes.

CV Event Risk Similar Regardless of Diabetes Diagnosis

CV Event Risk Similar Regardless of Diabetes Diagnosis

Statin and aspirin therapies in diabetes did not increased patients' risks of cardiovascular events.

FDA Approves Inclusion of LEADER Trial Data On Liraglutide Labeling

FDA Approves Inclusion of LEADER Trial Data On Liraglutide Labeling

Data from the 9300 patient LEADER trial is now eligible for inclusion on liraglutide injection packaging.

Acceptable Variability With Novel Sensor for Glucose Monitoring in T2D

Acceptable Variability With Novel Sensor for Glucose Monitoring in T2D

One hundred fifteen patients used the FreeStyle Libre Pro sensor to monitor interstitial fluid glucose for 14 days.

Positive Outcomes Associated With Regular Depression Screening in T2D

Positive Outcomes Associated With Regular Depression Screening in T2D

Undiagnosed depression in type 2 diabetes can lead to elevated hemoglobin A1c levels, frequent hospital admissions, and poor patient quality of life.

Best Practices in Preconception Care in Pregestational Diabetes

Best Practices in Preconception Care in Pregestational Diabetes

Special considerations are needed when treating women of reproductive age with pregestational diabetes.

Liraglutide, Metformin, and Gliclazide Compared in Comorbid Type 2 Diabetes and Nonalcoholic Fatty Liver Disease

Liraglutide, Metformin, and Gliclazide Compared in Comorbid Type 2 Diabetes and Nonalcoholic Fatty Liver Disease

Liraglutide and metformin yielded higher reductions in HbA1c levels when compared with gliclazide.

Patient Preferences Affect Efficacy of Diabetes Care

Patient Preferences Affect Efficacy of Diabetes Care

Patients were surveyed to determine their personal preferences when receiving diabetes education and self-management direction.

Exercise Protocol Improves Outcomes in T2D

Exercise Protocol Improves Outcomes in T2D

Exercise regimens were prescribed based on individual disease states: diabetes without complications, diabetic retinopathy, diabetic nephropathy, diabetic autonomic neuropathy, or diabetic peripheral neuropathy.

Type 2 Diabetes Death and CV Events Predicted by Systolic Blood Pressure Variability

Type 2 Diabetes Death and CV Events Predicted by Systolic Blood Pressure Variability

For patients with type 2 diabetes, visit-to-visit variability in systolic blood pressure may function as an independent predictor for cardiovascular events.

ADA: Clinical Benefit With Alirocumab in T2D Plus Statin Therapy

ADA: Clinical Benefit With Alirocumab in T2D Plus Statin Therapy

Researchers presented data from the ODYSSEY DM Insulin and Dyslipidemia trials at ADA 2017.

Semaglutide Improved Beta-Cell Function and Glycemic Control in Type 2 Diabetes

Semaglutide Improved Beta-Cell Function and Glycemic Control in Type 2 Diabetes

Semaglutide significantly increased insulin response and was well-tolerated in patients with type 2 diabetes.

Cardiometabolic Disease Staging Score Useful in Quantifying T2D Risk in Overweight, Obesity

Cardiometabolic Disease Staging Score Useful in Quantifying T2D Risk in Overweight, Obesity

Cardiometabolic Disease Staging scores can be used to quantify diabetes risk and assess efficacy of weight loss pharmacotherapy in obesity.

Blood Glucose Self-Monitoring in Type 2 Diabetes Does Not Benefit Glycemic Control

Blood Glucose Self-Monitoring in Type 2 Diabetes Does Not Benefit Glycemic Control

There were no significant differences in hemoglobin A1c across the 3 self-monitoring blood glucose groups.

Improving Glycemic Control in T2D With Text Message Intervention

Improving Glycemic Control in T2D With Text Message Intervention

Three-times daily text messages over a 6 month period were found to improve glycemic control vs usual care.

Major Cardiovascular Event Incidence in T2D: Degludec vs Glargine

Major Cardiovascular Event Incidence in T2D: Degludec vs Glargine

Degludec is noninferior to glargine in terms of incidence of major cardiovascular events in patients with type 2 diabetes at high cardiovascular risk.

Pooled Analysis Demonstrates Safety, Tolerability of Empagliflozin

Pooled Analysis Demonstrates Safety, Tolerability of Empagliflozin

A pooled analysis examined the rates of amputation and fracture in patients with type 2 diabetes prescribed empagliflozin.

FDA: Application Submitted for CV Safety Data Review of Insulin Degludec

FDA: Application Submitted for CV Safety Data Review of Insulin Degludec

The FDA is poised to review data from the DEVOTE trial, examining the rates of major adverse cardiovascular events in insulin degludec vs insulin glargine.

Cruciferous Vegetables May Regulate Dysglcemia In Obesity With T2D

Cruciferous Vegetables May Regulate Dysglcemia In Obesity With T2D

Sulforaphane extract from cruciferous vegetables aids in dysglycemia regulation in patients with obesity and type 2 diabetes.

Extended-Release Naltrexone/Bupropion Efficacious for Weight Loss in Type 2 Diabetes

Extended-Release Naltrexone/Bupropion Efficacious for Weight Loss in Type 2 Diabetes

Two studies examined the effects of naltrexone/bupropion on weight loss, glycemic parameters, and cardiovascular risks in patients with type 2 diabetes.

Liraglutide Does Not Increase Risk for Acute Pancreatitis in Type 2 Diabetes

Liraglutide Does Not Increase Risk for Acute Pancreatitis in Type 2 Diabetes

Liraglutide does not increase the risk for acute pancreatitis in patients with type 2 diabetes who are also at high risk for cardiovascular events.

Sign Up for Free e-Newsletters

CME Focus